An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments-Reference-Cited by-同舟云学术

An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments

Published:2012-04-23 Issue:2 Volume:152 Page:171-183
ISSN:1756-2651
Container-title:The Journal of Biochemistry
language:en
Short-container-title:

Author:

Tomitsuka Eriko,Kita Kiyoshi,Esumi Hiroyasu

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Biochemistry,General Medicine

Link

http://academic.oup.com/jb/article-pdf/152/2/171/14114222/mvs041.pdf

Reference49 articles.

1. Exploiting tumour hypoxia in cancer treatment;Brown;Nat. Rev. Cancer,2004

2. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review;Vaupel;Cancer Res.,1989

3. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry;Hirayama;Cancer Res.,2009

4. On respiratory impairment in cancer cells;Warburg;Science,1956

5. Cancer metabolism: facts, fantasy, and fiction;Zu;Biochem. Biophys. Res. Comm.,2004

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses;Scientific Reports;2024-08-21

2. Toxic Effects of Penetrating Cations;Membranes;2023-10-22

3. Metabolic modulation of mitochondrial mass during CD4+ T cell activation;Cell Chemical Biology;2023-09

4. The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression;Cancers;2022-12-26

5. Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug;Biomedicines;2022-12-14